Month: July 2026

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) announced on July 9, 2026 that the European Medicines Agency has completed its review and will allow use of commercially manufactured GP2 in the FLAMINGO-01 Phase III trial across European sites. The clinical-stage biopharmaceutical company is developing GLSI-100, an immunotherapy designed to prevent breast cancer recurrences. The company manufactured the … Read more

Losing weight or rebuilding energy takes more than a prescription alone. A medication can curb appetite or support metabolism, but staying consistent with dosing, managing side effects, and keeping motivation up over months of treatment is a separate challenge entirely. Many telehealth services ship the medication and leave the rest up to the patient. Brello … Read more

Perimenopause symptoms rarely show up one at a time. Irregular periods might overlap with sudden mood swings, and just as those settle, sleep problems or hot flashes take their place. Many women bring these changes to a general practitioner only to feel brushed aside, since most primary care visits aren’t built for the level of … Read more

Irvine, California – July 8, 2026. Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) announced today that it has acquired iRenix Medical, Inc., a privately held, clinical-stage ophthalmic biopharmaceutical company.  The deal brings Tarsus the rights to IRX-101, an investigational ocular antiseptic designed to reduce post-procedural pain and corneal toxicity in patients undergoing intravitreal injections.  Tarsus completed the … Read more

Zurich, Switzerland – July 9, 2026. Cytosurge AG, a company specializing in same-cell biology, announced today that a study conducted with the Technical University of Denmark (DTU) has been published open-access in the peer-reviewed journal JCI Insight.  The research maps out how a protein called dermokine governs skin cell adhesion, pointing toward new treatment targets … Read more

Hormone replacement therapy often means juggling a patch, a pill, and a separate cream just to cover the basics. Inner Balance Oestra combines bioidentical estradiol and progesterone into a single vaginal hormone cream, aiming to simplify that routine into one daily application. Take a look into how the treatment works, what it costs, real customer … Read more

Low sexual desire affects a large number of women, yet most treatment options were originally built for men or rely on hormones alone. Inner Balance Libida takes a different approach with a prescription sublingual tablet designed to target the brain’s desire pathways directly.  Quick Verdict: Inner Balance Libida suits women who want an on-demand, non-hormonal … Read more

Every woman knows the frustration of trying to stay on top of her health while juggling work, family, and a schedule that never slows down. Metabolism starts to feel unpredictable. Cravings hit at the worst times. Energy dips right when you need it most. That’s where a women’s wellness supplement like Hormovance enters the conversation. … Read more